Israel M. Barbash, MD

Original Contribution

Outcomes of Patients Turned Down for Percutaneous Mitral Valve Repair

11/01/2020

Binyamin B. Neeman ;

Ilan Hai , MD;

Ori Vaturi , MD;

Sagit Ben Zekry , MD;

Victor Guetta , MD;

Israel M. Barbash , MD;

Elad Maor , MD, PhD;

Micha Feinberg , MD;

Amit Segev , MD;

Paul Fefer , MD;

Percutaneous mitral valve repair is an alternative treatment for high-risk patients with symptomatic mitral regurgitation. Our study aimed to assess the reasons for and outcomes of patients who were declined MitraClip implantation and compare...

Percutaneous mitral valve repair...

11/01/2020

Journal of Invasive Cardiology

Original Contribution

Long-Term Safety and Efficacy of the Everolimus-Eluting Stent Compared to First-Generation Drug-Eluting Stents in Contemporary Clinical Practice

05/21/2014

Itsik Ben-Dor , MD;

Salem Badr , MD;

Joshua Loh , MD;

Sa'ar Minha , MD;

Ron Waksman , MD;

Lowell F. Satler , MD;

Augusto D. Pichard , MD, FACC, FSCAI;

Israel M. Barbash , MD;

Rebecca L. Torguson , BS, MPH;

A comparison of the long-term safety and clinical effectiveness of the Xience V everolimus-eluting stent to both the Taxus paclitaxel-eluting stent and the Cypher sirolimus-eluting stent in an unselected patient population.

A comparison of the long-term...

05/21/2014

Journal of Invasive Cardiology

Original Contribution

Favorable Short-Term and Long-Term Outcomes Among Patients With Prior History of Malignancy Undergoing Transcatheter Aortic Valve Implantation

02/25/2018

Yoni Grossman , MD;

Arwa Younis , MD;

Rafael 'Rafi' Kuperstein , MD;

Micha Feinberg , MD;

Elad Asher , MD;

Amit Segev , MD;

Paul Fefer , MD;

Anat Berkovitch , MD;

Victor Guetta , MD;

Israel M. Barbash , MD;

Noam Fink , MD;

Ehud Regev , MD;

Elad Maor , MD, PhD;

Yotam Vered , BA;

We investigated 477 patients who underwent TAVR and divided subjects into two groups according to malignancy status. We found that mere history of malignancy among elderly patients does not adversely affect outcomes after TAVR; however,...

We investigated 477 patients who...

02/25/2018

Journal of Invasive Cardiology

Original Contribution

Echocardiography vs Hemodynamic Assessment of Diastolic Dysfunction

01/12/2024

Rafael 'Rafi' Kuperstein , MD;

Amit Segev , MD;

Lital Shaham , MD, PhD;

Paul Fefer , MD;

Lior Fisher , MD;

Batla Falach , MD;

Ilan Hai , MD;

Ori Vaturi , MD;

Victor Guetta , MD;

Israel M. Barbash , MD;

Elad Maor , MD, PhD;

The study's aim was to evaluate the added value of invasive hemodynamic assessment in patients with unexplained shortness of breath (SOB) undergoing echocardiographic assessment using the most accepted echocardiographic definition of...

The study's aim was to evaluate...

01/12/2024

Journal of Invasive Cardiology

Original Contribution

Generational Differences in Outcomes of Self-Expanding Valves for Transcatheter Aortic Valve Replacement

04/01/2022

Shmuel Banai , MD;

Haim Danenberg , MD;

Aviram Hochstadt , MD;

Itamar Loewenstein , MD;

David Zahler , MD;

Ariel Finkelstein , MD;

Hana Vaknin-Assa , MD;

Yan Topilsky , MD;

Katia Orvin , MD;

Maayan Konigstein , MD;

Shmuel Bazan , MD;

David Planner , MD;

Arie Steinvil , MD;

Amir Halkin , MD;

Abid R. Assali , MD;

Victor Guetta , MD;

Ran Kornowski , MD;

Israel M. Barbash , MD;

Amit Segev , MD;

The Medtronic Evolut Pro valve (EPV) is a new-generation self-expanding valve (SEV), particularly designed to reduce paravalvular leak (PVL) rates in transcatheter aortic valve replacement (TAVR). We aimed to compare the safety and efficacy...

The Medtronic Evolut Pro valve...

04/01/2022

Journal of Invasive Cardiology